Novartis Contract Manufacturing is the CDMO arm of Novartis, offering fully integrated end-to-end manufacturing solutions across biologics (mammalian up to 15,000L, microbial up to 13,000L), small molecules (API to fill & finish), cell & gene therapy (CAR-T, AAV, LV), xRNA/LNP/pDNA, and comprehensive fill & finish services. The operation spans multiple state-of-the-art facilities across Austria, Switzerland, Slovenia, Belgium, France, Singapore, and the United States, with 107 FDA inspections and 27 FEI registrations.
integrated biologics CDMO (mammalian and microbial), cell & gene therapy (CAR-T, viral vectors), mRNA/LNP/pDNA manufacturing, small molecule API and drug product, global multi-site fill & finish
11 sites worldwide
Involvement in 4 clinical trials
No reviews available yet.
No documents available.